Tempe, AZ, United States of America

Seth David Rose

This inventor holds 17 USPTO granted patents and 1 published patent application, plus 3 CIPO patents and 4 EPO patents, primarily in Biomedical Engineering. Top assignees: Arizona Biomedical Research Commission, Philip Morris Products S.a., The Arizona Disease Control Research Commission. Active years: 2001-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Seth David Rose. Retrieved from https://idiyas.com/inventor/seth-david-rose

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 17 

% Patents Active = 52.9

 

 

Average Co-Inventor Count = 3.8

ph-index = 6

Forward Citations = 548(Granted Patents)


Location History:

  • Tempe, AR (US) (2006)
  • Tempe, AZ (US) (2001 - 2022)

Company Filing History:


Years Active: 2001-2022

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
SARS-CoV-2 Detection
Cancer Therapeutics
Drug Delivery
Tobacco Aerosol Generation
Modified Chalcone Compounds
Conjugated Nitro Alkenes
Protein Prenylation
Protective Films
Long-Acting Emollients
Antimitotic Agents
17 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Inventor Seth David Rose

Introduction

Seth David Rose is a notable inventor based in Tempe, AZ, with a remarkable portfolio of 17 patents. His work primarily focuses on advancements in medical technology and public health, particularly in the context of rapid disease detection and therapeutic delivery systems.

Latest Patents

One of his latest patents is a method and apparatus for rapid detection of SARS-CoV-2. This innovative approach allows for the comfortable, rapid, and inexpensive collection of samples from test subjects, which can be analyzed for the presence of the virus. The method utilizes saliva, nasal drainage, or other body fluids, examined through fluorimetry. This mass rapid screening technique serves as a valuable public health tool to mitigate the transmission of COVID-19 while enabling business activities to resume. Another significant patent is a device and method for the delivery of a medicament. This disclosure enhances the concentrations of nicotine or other medicaments in a gaseous carrier, adaptable for therapeutic effects in various diseases, particularly for tobacco cessation and harm reduction.

Career Highlights

Seth David Rose has contributed to significant advancements in biomedical research through his work with the Arizona Biomedical Research Commission and Philip Morris Products S.A. His innovative approaches have paved the way for new methodologies in health technology.

Collaborations

Throughout his career, Seth has collaborated with notable professionals, including Rosemarie F. Hartman and Karl J. Okolotowicz. These collaborations have further enriched his research and development efforts.

Conclusion

Seth David Rose's contributions to the fields of medical technology and public health are noteworthy. His innovative patents reflect a commitment to improving health outcomes and advancing scientific knowledge.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…